Diem Michael Craig
SEC CIK 1497624 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | Chief Business Off | 253.5K | — | — | 3 | 2023-02-02 | 2023-11-01 |
Most active insiders at IPSC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pfeiffenberger Brent | Pres, CEO, Dir | $47.7K | $14.6K |
| 2 | Cowan Chad | CSO | $49.4K | $2,731 |
| 3 | Russotti Gregory | See Remarks | — | $40.2K |
| 4 | Carr Douglas | SVP Fin, Ops | — | $28.6K |
Diem Michael Craig made no open-market trades at IPSC in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-03 | 2023-11-01 | IPSC | Century Therapeutics, Inc. | Diem Michael Craig | CFO | F - Tax | $1.49 | -20.8K | 253.5K | -8% | -$30.9K | |
| 2023-05-17 | 2023-05-15 | IPSC | Century Therapeutics, Inc. | Diem Michael Craig | CFO | A - Grant | $0.00 | +151.1K | 274.3K | +123% | $0 | |
| DM | 2023-02-06 | 2023-02-02 | IPSC | Century Therapeutics, Inc. | Diem Michael Craig | Chief Business Off | A - Grant | $0.00 | +43.8K | 101.4K | +76% | $0 |
Purchase Sale Sale after option exercise All abbreviations